J. Goldman & Co »

Capricor Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.4M 617k 7.21

More positions owned by J. Goldman & Co

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Maplebear (CART)
Steven Madden (SHOO)
Rocket Cos Com Cl A (RKT)
Sba Communications Corp Cl A (SBAC)
Amazon (AMZN)
Paypal Holdings (PYPL)
General Motors Company (GM)
Globus Med Cl A (GMED)
Centuri Holdings Com Shs (CTRI)
Rivian Automotive Com Cl A Call Option (RIVN)
Target Corporation (TGT)

View all positions for J. Goldman & Co

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Morgan Stanley
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/

View all funds holding Capricor Therapeutics